Notice of Extension of Application Due Dates for PAR-16-052 "Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21)"

Notice Number: NOT-TW-17-001

Key Dates
Release Date: November 8, 2016

Related Announcements
PAR-16-052

Issued by
Fogarty International Center (FIC)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Center for Complementary and Integrative Health (NCCIH)
National Institute on Aging (NIA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Drug Abuse (NIDA)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
Office of Behavioral and Social Sciences Research (OBSSR)
Office of Dietary Supplements (ODS)
Office of Research on Women’s Health (ORWH)

Purpose

The purpose of this Notice is to inform interested applicants of additional participating IC language and an additional application due date for the Funding Opportunity Announcement (FOA) PAR-16-052 "Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21)". An additional application due date, December 14, 2017, has been added for this FOA. As usual, applications are due by 5:00 PM local time of the applicant organization. This FOA expires on December 15, 2017.

Part 1. Overview Information

Key Dates

Currently reads:


Posted Date

December 9, 2015

Open Date (Earliest Submission Date)

January 24, 2016  

Letter of Intent Due Date

30 days before the application due date

Application Due Date(s)

February 24, 2016; February 22, 2017 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

February 24, 2016; February 22, 2017 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

June 2016, June 2017

Advisory Council Review

August, 2016 August 2017

Earliest Start Date(s)

September 2016, September 2017

Expiration Date

February 23, 2017

Due Dates for E.O. 12372

Not Applicable

 

Revised to read:


Posted Date

December 9, 2015

Open Date (Earliest Submission Date)

January 24, 2016  

Letter of Intent Due Date

30 days before the application due date

Application Due Date(s)

February 24, 2016; February 22, 2017; December 14, 2017 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)

February 24, 2016; February 22, 2017; December 14, 2017 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

June 2016, June 2017, March 2018

Advisory Council Review

August, 2016 August 2017, May 2018

Earliest Start Date(s)

September 2016, September 2017, April 2018

Expiration Date

December 15, 2017

Due Dates for E.O. 12372

Not Applicable

 

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Research Interests of the FOA Sponsors

National Institute of Nursing Research (NINR) participation in this FOA is limited to HIV/AIDS-related research that addresses the Office of AIDS Research Priority to “improve prevention or treatment of HIV-associated comorbidities and co-infections.” Please contact the NINR Scientific/Research contact noted on the FOA for questions about this announcement.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Kathleen Michels, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-496-1653
Email: FIC-NCD@mail.nih.gov